A Swedish research team reported that over-expression of SPARCL1 protein in the primary colorectal carcinomas had a short survival [15], while the diametrically opposing conclusions were drawn by Hu and colleagues through western blot and immunohistochemistry [17]. This evidence concerns the gene SPARCL1 and colorectal carcinoma.